TILS.L Regulatory News (TILS)

20 Nov 2007 12:08

ReGen Therapeutics PLC20 November 2007 Results of Extraordinary General Meeting ReGen Therapeutics Plc (the "Company") announces that, at the ExtraordinaryGeneral Meeting of the Company held earlier today, Shareholders passed all theresolutions including the resolution relating to the proposed share capitalconsolidation of the Company, as detailed in the circular sent to Shareholdersdated 26 October 2007 (the "Capital Consolidation"). The expected timetable for the Capital Consolidation is as follows: Record Date for Capital Consolidation: 6.00 p.m. on 20 November 2007 Commencement of Dealings in New Ordinary Shares 8.00 a.m. on 21 November 2007 CREST Accounts credited with New Ordinary Shares 21 November 2007 Despatch of certificates for New Ordinary Shares by 27 November 2007 Despatch of cheques for fractional entitlements and certificates for New Ordinary Shares; CREST accounts credited with value of fractional entitlements by 10 December 2007 Application has been made to the London Stock Exchange for the New OrdinaryShares arising on the Capital Consolidation to be admitted to trading on AIM on21 November 2007. Notes: If any of the above times and/or dates change, the revised times and/or dateswill be notified to Shareholders by announcement through a RegulatoryInformation Service. References to time in this announcement and the Notice of Extraordinary GeneralMeeting are to British Time. For further enquiries: Percy Lomax, Chairman and Chief Executive, ReGen Therapeutics Plc Tel: 020 7153 4920 Direct: 020 8504 2156 Mobile: 07932 751541 Roland Cornish, Beaumont Cornish Limited Tel: 020 7628 3396 Nick Bealer, King & Shaxson Capital Limited Tel: 020 7426 5986 Andrew Marshall, Greycoat Communications Tel: 020 7960 6007 Mobile: 07785 297111 This information is provided by RNS The company news service from the London Stock Exchange